| Using Web to Curb Waiting-Room Times A Web-based application, called MedWaitTime, allows patients to check before their appointment whether their doctor is running late, akin to getting a flight status update before going to the airport. online.wsj.com |
Mannkind Tries Again With Inhaled Insulin The Burrill Report submits: By Michael Fitzhugh Mannkind (MNKD) says it has resubmitted a once-rejected new drug application to the U.S. Food and Drug Administration for its inhaled insulin-and-inhaler combination, Afrezza, securing a promise of agency action on the drug by the end of 2010.Complete Story » seekingalpha.com |
Genoptix Announces Participation at 2010 Southern California Investor Conference (PR Newswire) Genoptix, Inc. , a specialized laboratory services provider, today announced the Company's participation at the Southern California Investor Conference to be held August 17, 2010 at The Island Hotel, Newport Beach, CA. us.rd.yahoo.com |
Healthcare Headlines: Santarus Rallies, Amgen Announces Results M.E. Garza submits: Below is a look at some of the headlines for companies that made news in the healthcare sector on October 5, 2010. Santarus, Inc. (NASDAQ:SNTS), a specialty biopharmaceutical company, announced the publication of an integrated analysis of two randomized placebo-controlled clinical trials with RHUCIN (recombinant human C1 inhibitor, or rhC1INH), in the October issue of the peer reviewed Journal of Allergy and Clinical Immunology (JACI).Complete Story » seekingalpha.com |
Aegerion's IPO Prices Well Below Expectations: The Week in Biotech Deals The Burrill Report submits: By Marie DaghlianAegerion Pharmaceuticals (AEGR) expected to price its shares at $14 to $16 to go public this week, but with no takers by Friday morning, it lowered its offering price to $9.50 a share. The Bridgewater, New Jersey drug developer sold 5 million shares to raise $47 and began trading on the Nasdaq Global Market under the symbol AEGR. In its first day of trading, its price rose slightly to $10.80. Complete Story » seekingalpha.com |